<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="240" ids="33364,33400">Platinum</z:chebi>-containing anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> drugs such as <z:chebi fb="2" ids="27899">cisplatin</z:chebi> are widely used for patients with various types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, however, resistance to <z:chebi fb="2" ids="27899">cisplatin</z:chebi> is observed in some cases </plain></SENT>
<SENT sid="1" pm="."><plain>Whereas we have recently reported that high dose UV-C (200 J/m²) induces <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell proliferation by desensitization of EGFR, which leads oncogenic signaling in these cells, in this study we investigated the combination effect of low dose <z:chebi fb="2" ids="27899">cisplatin</z:chebi> (10 μM) and low dose UV-C (10 J/m²) on cell growth and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in several human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells, SW480, DLD-1, HT29 and HCT116 </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The combination inhibited cell cycle and colony formation, while either <z:chebi fb="2" ids="27899">cisplatin</z:chebi> or UV-C alone had little effect </plain></SENT>
<SENT sid="3" pm="."><plain>The combination also induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in these cells </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, the combination caused the downregulation of EGFR and HER2 </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, UV-C alone caused the transient internalization of the EGFR, but with time EGFR recycled back to the cell surface, while <z:chebi fb="2" ids="27899">cisplatin</z:chebi> did not affect its localization </plain></SENT>
<SENT sid="6" pm="."><plain>Surprisingly, the combination caused persistent internalization of the EGFR, which results in the lasting downregulation of the EGFR </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The combination of low dose <z:chebi fb="2" ids="27899">cisplatin</z:chebi> and low dose UV-C synergistically exerted anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> effect by down-regulating RTK, such as EGFR and HER2 </plain></SENT>
<SENT sid="8" pm="."><plain>These findings may provide a novel strategy for the treatment of patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>